Preclinical News and Research

RSS
Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Oncoceutics, MD Anderson partner to develop novel anti-cancer drug

Study: Placental cells may possibly treat damaged nerves

Study: Placental cells may possibly treat damaged nerves

Tikcro enters into research and license agreement with Yeda

Tikcro enters into research and license agreement with Yeda

Kinex Pharmaceuticals doses first patient with KX2-361 in ‘A Phase 1’ clinical trial

Kinex Pharmaceuticals doses first patient with KX2-361 in ‘A Phase 1’ clinical trial

Bio2 Technologies' CLM Bioactive Scaffold receives FDA clearance

Bio2 Technologies' CLM Bioactive Scaffold receives FDA clearance

New training network project to develop medical statisticians to achieve drug development success

New training network project to develop medical statisticians to achieve drug development success

Investigational drug increases PFS in patients with advanced breast cancer

Investigational drug increases PFS in patients with advanced breast cancer

Preclinical study strongly supports NT-113 as potential new treatment for glioblastoma multiforme

Preclinical study strongly supports NT-113 as potential new treatment for glioblastoma multiforme

Pre-clinical studies confirm TRXE-009 as new potential treatment for melanoma

Pre-clinical studies confirm TRXE-009 as new potential treatment for melanoma

Curie-Cancer, GamaMabs Pharma extend partnership to develop 3C23K drug for gynecological cancers

Curie-Cancer, GamaMabs Pharma extend partnership to develop 3C23K drug for gynecological cancers

Sensitive toxicity test aims to detect dangerous side effects in pharmaceutical development

Sensitive toxicity test aims to detect dangerous side effects in pharmaceutical development

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

ETH Zurich, University of Zurich jointly open new translational research centre

ETH Zurich, University of Zurich jointly open new translational research centre

ALS Association announces research funds to further understand genetic cause of ALS

ALS Association announces research funds to further understand genetic cause of ALS

Figitumumab development discontinued for non-adenocarcinoma NSCLC

Figitumumab development discontinued for non-adenocarcinoma NSCLC

Research finding could lead to new therapies for malignant glioma

Research finding could lead to new therapies for malignant glioma

Scientists to explore biology of human asthma by using slime mould

Scientists to explore biology of human asthma by using slime mould

Genetic variations may contribute to treatment-related cognitive problems in children with ALL

Genetic variations may contribute to treatment-related cognitive problems in children with ALL

Bayer, DNDi sign first agreement to develop new oral treatment for onchocerciasis

Bayer, DNDi sign first agreement to develop new oral treatment for onchocerciasis

Epizyme's PRMT5 inhibitor shows efficacy in pre-clinical models of mantle cell lymphoma

Epizyme's PRMT5 inhibitor shows efficacy in pre-clinical models of mantle cell lymphoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.